title: Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.
abstract: Topical photodynamic therapy (PDT) is used to treat nonmelanoma skin cancers, such as actinic keratoses, Bowen's disease, and basal cell carcinoma (superficial and nodular). This article presents up-to-date, practical, evidence-based recommendations on the use of topical PDT using 5-aminolevulinic acid or methyl aminolevulinate for the treatment (and prevention) of nonmelanoma skin cancers. A systematic literature review was conducted (using MEDLINE), and recommendations were made on the basis of the quality of evidence for efficacy, safety/tolerability, cosmetic outcome, and patient satisfaction/preference. Topical PDT is highly effective in the treatment of actinic keratoses, Bowen's disease, superficial and thin nodular basal cell carcinomas, with cosmesis typically superior to that achieved with existing standard therapies. PDT may also be a means of preventing certain nonmelanoma skin cancers in immunosuppressed patients.
authors.affiliation: Dermatological University Clinic, Bern, Switzerland. lasse.r.braathen@insel.ch
authors.forename: Lasse R
authors.initials: LR
authors.lastname: Braathen
authors.forename: Rolf-Markus
authors.initials: RM
authors.lastname: Szeimies
authors.forename: Nicole
authors.initials: N
authors.lastname: Basset-Seguin
authors.forename: Robert
authors.initials: R
authors.lastname: Bissonnette
authors.forename: Peter
authors.initials: P
authors.lastname: Foley
authors.forename: David
authors.initials: D
authors.lastname: Pariser
authors.forename: Rik
authors.initials: R
authors.lastname: Roelandts
authors.forename: Ann-Marie
authors.initials: AM
authors.lastname: Wennberg
authors.forename: Colin A
authors.initials: CA
authors.lastname: Morton
mesh_terms: D000622:Aminolevulinic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D001478:Basal Cell Nevus Syndrome / Q000188:drug therapy; D001913:Bowen's Disease / Q000188:drug therapy; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004311:Double-Blind Method; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D007642:Keratosis / Q000188:drug therapy; D015337:Multicenter Studies as Topic; D017060:Patient Satisfaction; D010778:Photochemotherapy / Q000379:methods / Q000592:standards; D010787:Photosensitivity Disorders / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012871:Skin Diseases / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology
chemical_list: C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid